PHD Discussions Logo

Ask, Learn and Accelerate in your PhD Research

Question Icon Post Your Answer

Question Icon

2 years ago in Clinical Pharmacology By Vinod D

What are the clinically significant drug interactions involving atropine that practitioners need to be aware of?

I'm compiling a safety checklist for our pharmacy. Beyond additive anticholinergic effects, are there specific interactions with other medication classes—like antipsychotics, antidepressants, or antiarrhythmics—that are particularly dangerous or that alter atropine's metabolism?

All Answers (1 Answers In All)

By Ridhima Malhotra Answered 1 year ago

The primary concern is additive anticholinergic toxicity. Combining atropine with other antimuscarinics (e.g., scopolamine), tricyclic antidepressants, first-generation antipsychotics, or antihistamines like diphenhydramine can precipitate delirium, hyperthermia, ileus, and urinary retention. From a cardiac perspective, concurrent use with other heart rate-increasing drugs (e.g., beta-agonists, theophylline) can provoke dangerous tachycardia. There are few major pharmacokinetic interactions, as atropine is metabolized broadly. The key clinical rule is to carefully review a patient's medication list for any agent with anticholinergic properties and monitor vigilantly for the cumulative "anticholinergic burden," especially in elderly patients.

 

Your Answer